Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Active not recruiting 3

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Thoracic 1Other solid neoplasm 1Genitourinary 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 12Oropharyngeal Neoplasms 11Lung Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Mouth Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Hypopharyngeal Neoplasms 6Nasopharyngeal Carcinoma 5Mesothelioma, Malignant 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Uterine Cervical Neoplasms 3Lymphoid Interstitial Pneumonia 3Gallbladder Neoplasms 3Triple Negative Breast Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Ovarian Neoplasms 2Medulloblastoma 2Ganglioneuroblastoma 2Cholangiocarcinoma 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1

Interventions

pembrolizumab 14Cisplatin 13Specimen Handling 11Magnetic Resonance Spectroscopy 7Brachytherapy 7Bevacizumab 7Radiotherapy 6atezolizumab 5Platinum 5Paclitaxel 5Nivolumab 5Human Papillomavirus DNA Tests 5Gemcitabine 5Colposcopy 5Carboplatin 5Blood Specimen Collection 5Radiation 4Fulvestrant 4lenvatinib 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Drug Therapy 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3zimberelimab 2tisotumab vedotin 2spartalizumab 2palbociclib 2camrelizumab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × 90 days × Clear all
NCT02466971 2026-05-29

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02595879 2026-05-29

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled 22 charts
Gynecologic

Uterine Cervical Neoplasms

NCT04491942 2026-04-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
74 enrolled
BreastGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡